New Strain of Rickettsia Bacteria That Causes Spotted Fever Infections in Humans Identified
Researchers discovered a novel Rickettsia bacteria in rabbit ticks that may help explain rare but serious spotted fever cases in New England.
Researchers discovered a novel Rickettsia bacteria in rabbit ticks that may help explain rare but serious spotted fever cases in New England.
A new noninvasive malaria test can detect malaria-infected cells in the bloodstream without requiring a blood sample.
Roche announced its continued support in addressing the global mpox emergency by partnering with healthcare providers and organizations.
George Mason University researchers have been awarded over $1 million to develop a urine-based Lyme disease test.
Read MoreThe FDA granted EUA for Labcorp’s Mpox PCR Test Home Collection Kit, facilitating the early detection and management of mpox infections.
Read MoreResearchers developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests.
Read MoreA study showcased the application of Flongle sequencing as a cost-efficient and rapid method to detect the zoonotic pathogen.
Read MorePicodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read MoreA new study has revealed disparities in the diagnosis and treatment of Lyme disease between Black and White patients with the condition.
Read MoreA pilot study demonstrated the importance of self-sampling in diagnosing asymptomatic or atypical cases of mpox.
Read MoreCurrent diagnostic methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood.
Read MoreA rapid test for mpox has been developed that can detect the virus within minutes, without the use of any high-end instrumental techniques.
Read MoreNoze received a grant of $1 million to build a breathalyzer, powered by its platform, to detect breath biomarkers (VOCs).
Read MoreCue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read MoreThe test kit is for use in laboratory settings and can help healthcare professionals accurately identify an Avian Influenza A Virus infection.
Read MoreThe FDA issued an emergency use authorization for the Cepheid Xpert Mpox (monkeypox) test for use in a point-of-care setting.
Read MoreA new study identified Raman spectroscopy as a promising diagnostic approach for Lyme disease, according to the Bay Area Lyme Foundation.
Read MoreMicrobix Biosystems is launching a new quality assessment product to support molecular diagnostic testing for the non-variola orthopoxvirus.
Read More